{"url_path":"/sec/ogen/8-k/2026-07-06/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1174940/0001493152-26-032155-index.html","accession_number":"0001493152-26-032155","cik":"0001174940","ticker":"OGEN","issuer_name":"ORAGENICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1174940/0001493152-26-032155-index.html","primary_entity_key":"0001174940","primary_entity_name":"ORAGENICS INC"},"word_count":109,"has_tables":true,"body_markdown":"****\n\n \n\n**Item 1.01**\n**ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT**\n\n \n\nEffective\nJuly 1, 2026, the Board of Directors (the “Board”) of Oragenics, Inc. (the “Company”) appointed John Spencer,\nthe Company’s Senior Controller, to serve as the Company’s Chief Financial Officer, and, in connection therewith, effective\nJuly 1, 2026, the Company entered into an Executive Employment Agreement with Mr. Spencer (the “Employment Agreement”). The\nEmployment Agreement provides for base compensation of $200,000. The Employment Agreement contains customary confidentiality, non-competition\nand non-solicitation provisions.\n\n \n\nThe\nforegoing summary is qualified in its entirety by the specific terms of the Employment Agreement attached as Exhibit 10.1 to this Form\n8-K which is incorporated herein by reference."}